Skip to Main Content

Paper Details

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.
Pediatrics
32
2021
Adolescents, COVID-19, Children, Dyspnea, acute respiratory distress syndrome, anosmia, aspirin, bronchiolitis, cancer, children, coronavirus disease, famotidine, gastrointestinal symptoms, heart disease, hypoxemia, inflammatory syndrome, influenza, neurodevelopmental disorders, patients, pneumonia, seasonal influenza
Adolescent, Age Distribution, COVID-19, COVID-19 Drug Treatment, Child, Child, Preschool, Cohort Studies, Comorbidity, Databases, Factual, Diagnosis, Differential, Female, France, Germany, Hospitalization, Humans, Infant, Infant, Newborn, Influenza, Human, Male, Republic of Korea, Spain, Symptom Assessment, Time Factors, Treatment Outcome, United States
Author NameAffiliation
Talita Duarte-SallesFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Talita Duarte-SallesFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
David VizcayaBayer Pharmaceuticals
David VizcayaBayer Pharmaceuticals
Andrea PistilloFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Paula Casajust
Anthony G Sena
Anthony G SenaErasmus University Medical Center
Lana Y H LaiUniversity of Manchester
Albert Prats-Uribe
Albert Prats-Uribe
Waheed-Ul-Rahman Ahmed
Waheed-Ul-Rahman AhmedCollege of Medicine and Health, University of Exeter
Thamir M AlshammariKing Saud University
Thamir M AlshammariKing Saud University
Heba AlghoulIslamic University of Gaza
Osaid AlserMassachusetts General Hospital and Harvard Medical School, Harvard University
Edward BurnFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Edward Burn
Edward BurnFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Edward Burn
Seng Chan YouAjou University
Seng Chan YouAjou University
Carlos AreiaUniversity of Oxford
Clair Blacketer
Clair BlacketerErasmus University Medical Center
Scott L DuVall
Scott L DuVallUniversity of Utah
Scott L DuVall
Scott L DuVallUniversity of Utah
Thomas FalconerColumbia University
Thomas FalconerColumbia University
Sergio Fernandez-BertolinFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Stephen Fortin
Asieh GolozarRegeneron Pharmaceuticals
Asieh GolozarJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University
Mengchun Gong
Eng Hooi Tan
Vojtech HuserLister Hill National Center for Biomedical Communications, National Institutes of Health
Vojtech HuserLister Hill National Center for Biomedical Communications, National Institutes of Health
Pablo Iveli
Daniel R MoralesUniversity of Dundee
Daniel R MoralesUniversity of Dundee
Fred NybergSchool of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg
Fred NybergSchool of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg
Jose D PosadaStanford University
Martina RecaldeFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Martina RecaldeUniversitat Autonoma de Barcelona
Elena RoelFundacio Institut Universitari per a la Recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina
Lisa M SchillingUniversity of Colorado Anschutz Medical Campus
  • 1 - 50

Datasets

Release 1.2